These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3220460)

  • 41. Regulation of DNA synthesis in human fetal hepatocytes by placental lactogen, growth hormone, and insulin-like growth factor I/somatomedin-C.
    Strain AJ; Hill DJ; Swenne I; Milner RD
    J Cell Physiol; 1987 Jul; 132(1):33-40. PubMed ID: 3298289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats.
    Maiter D; Underwood LE; Maes M; Davenport ML; Ketelslegers JM
    Endocrinology; 1988 Aug; 123(2):1053-9. PubMed ID: 3396497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Actions of growth hormone, prolactin and thyroxine on serum somatomedin-like activity and growth in hypopituitary dwarf mice.
    Holder AT; Wallis M
    J Endocrinol; 1977 Aug; 74(2):223-9. PubMed ID: 894170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The polymorphic pattern of somatomedins during human development.
    Blum WF; Ranke MB; Lechner B; Bierich JR
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):445-51. PubMed ID: 3425159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification of a basic somatomedin, from human plasma Cohn fraction IV-1, with physicochemical and radioimmunoassay similarity to somatomedin-C and insulin-like growth factor.
    Bala RM; Bhaumick B
    Can J Biochem; 1979 Nov; 57(11):1289-98. PubMed ID: 575503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins.
    Van Wyk JJ; Svoboda ME; Underwood LE
    J Clin Endocrinol Metab; 1980 Jan; 50(1):206-8. PubMed ID: 7350184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The growth of different organs of normal and dwarfed Snell mice, before and during growth hormone therapy.
    van Buul-Offers S; Van den Brande JL
    Acta Endocrinol (Copenh); 1981 Jan; 96(1):46-58. PubMed ID: 7456983
    [No Abstract]   [Full Text] [Related]  

  • 48. Partial purification, characterization, and assay of a slightly acidic insulin-like peptide (ILAs) from human plasma.
    Posner BI; Guyda HJ; Corvol MT; Rappaport R; Harley C; Goldstein S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1240-50. PubMed ID: 400741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early paradoxical decrease in serum somatomedin activity following injection of growth hormone.
    Schimpff RM; Gourmelen M; Donnadieu M; Binoux M; Girard F
    J Clin Endocrinol Metab; 1978 Jan; 46(1):173-6. PubMed ID: 752020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A radioimmunoassay for insulin-like growth factor II specific for the C-peptide region.
    Hintz RL; Liu F
    J Clin Endocrinol Metab; 1982 Feb; 54(2):442-6. PubMed ID: 6172444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal antibody enhancement of the effects of human growth hormone on growth and body composition in mice.
    Holder AT; Blows JA; Aston R; Bates PC
    J Endocrinol; 1988 Apr; 117(1):85-90. PubMed ID: 3356959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin-like growth factors and aging.
    Hammerman MR
    Endocrinol Metab Clin North Am; 1987 Dec; 16(4):995-1011. PubMed ID: 3322823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Basic peptide with insulin-like activity in human serum.
    Sasaki N; Okabe T; Imai Y; Matsuzaki F; Kosaka K; Wakai K; Tsushima T
    Endocrinol Jpn; 1981 Apr; 28(2):157-67. PubMed ID: 7030722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Somatomedin-C/insulin-like growth factor I and vitamin D-induced growth.
    Clark SA; D'Ercole AJ; Toverud SU
    Endocrinology; 1986 Oct; 119(4):1660-5. PubMed ID: 3757906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of somatomedin-C/insulin-like growth factor I and growth hormone on cultured growth plate and articular chondrocytes.
    Trippel SB; Corvol MT; Dumontier MF; Rappaport R; Hung HH; Mankin HJ
    Pediatr Res; 1989 Jan; 25(1):76-82. PubMed ID: 2919122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Passive immunization against insulin-like growth factor-I does not inhibit growth hormone-stimulated growth of dwarf rats.
    Spencer GS; Hodgkinson SC; Bass JJ
    Endocrinology; 1991 Apr; 128(4):2103-9. PubMed ID: 1706266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measurement of insulin-like growth factor I (IGF-I) responsiveness of fibroblasts of children with short stature: identification of a patient with IGF-I resistance.
    Heath-Monnig E; Wohltmann HJ; Mills-Dunlap B; Daughaday WH
    J Clin Endocrinol Metab; 1987 Mar; 64(3):501-7. PubMed ID: 3818890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth responses following a single intra-muscular hGH plasmid administration compared to daily injections of hGH in dwarf mice.
    Higuti E; Cecchi CR; Oliveira NA; Vieira DP; Jensen TG; Jorge AA; Bartolini P; Peroni CN
    Curr Gene Ther; 2012 Dec; 12(6):437-43. PubMed ID: 22974419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal antibody against human somatomedin-C/insulin-like growth factor-I.
    Baxter RC; Axiak S; Raison RL
    J Clin Endocrinol Metab; 1982 Feb; 54(2):474-6. PubMed ID: 7033280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pituitary control of growth in the neonatal rat: effects of neonatal hypophysectomy on somatic and organ growth, serum insulin-like growth factors (IGF)-I and -II levels, and expression of IGF binding proteins.
    Glasscock GF; Gelber SE; Lamson G; McGee-Tekula R; Rosenfeld RG
    Endocrinology; 1990 Oct; 127(4):1792-803. PubMed ID: 1698146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.